ArticleJournal of lower genital tract disease2020
An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Article in Journal of lower genital tract disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Predictive Contribution of p16 Beyond HPV Genotype in the Histopathologic Detection of CIN2+ Lesions: A Real-World Cervical Biopsy Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- External validation of predictive models for high-grade cervical lesions in Thai women undergoing colposcopy: a retrospective external validation study.BMC cancer · 2026Article
- Role of COVID-19 in the persistence of cervical high-risk human papillomavirus: a non-randomized retrospective study.BMC women's health · 2026Article
- The Impact of COVID-19 Vaccination on HR-HPV Persistence and Cervical Cytology Outcomes: A Retrospective Study.International journal of women's health · 2026Article
- Cervical cytology screening in a newly established government medical college: A bethesda-based reporting analysis.Bioinformation · 2026Article
- Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.Viruses · 2024Review
- The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.Gynecologic oncology · 2023Article
- Altered vaginal eukaryotic virome is associated with different cervical disease status.Virologica Sinica · 2023Article
- p16Clinical and translational medicine · 2023Article
- Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China.Diagnostics (Basel, Switzerland) · 2022Article
- Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional study.Obstetrics & gynecology science · 2022Article
- Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.American journal of clinical pathology · 2022Article
- Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?AIDS research and therapy · 2021Article
- Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16BMC infectious diseases · 2021Observational
- Understanding HPV-positive women's needs and experiences in relation to patient-provider communication issues: a qualitative study.BMC health services research · 2021Article
- Iranian women's psychological responses to positive HPV test result: a qualitative study.BMC women's health · 2021Article
- Article
- The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening.Journal of the National Cancer Institute · 2021Article
- Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening.International journal of cancer · 2020Review
- Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States.American journal of clinical pathology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.